Who We Are
We are a dedicated team of clinical research experts commited to improving clinical trial diversity. We equip clinical research professionals with the knowledge and skills to enroll more representative patient populations into clinical trials to ensure that medicines are safe and effective for all people. We do this by offering an eLearning and instructor-led clinical trial diversity training and certification course.
Our Commitment to Clinical Research Professionals
We partner with clinical research professionals, offering solutions to ensure the recruitment process is not only efficient, but also representative of diverse populations. Knowing that medical conditions often intersect with diverse genetic, socio-economic, and environmental factors, it is imperative that clinical trials reflect the intended users of the medical innovation.
Our Leadership Team
Otis Johnson, PhD, MPA (he/him)
Otis Johnson stands out as a leading authority in clinical research and championing diversity within the pharmaceutical industry. His career began with a transformative 13-year tenure at Merck & Co., where he played a critical role in the approval of Singulair for exercise-induced bronchospasm and helped establish the Global Trial Optimization group. His expertise flourished at Syneos Health and ICON, where he spearheaded advancements in clinical development strategies, focusing on feasibility, clinical informatics, and patient recruitment.
As a product management executive at Clario, Otis significantly contributed to the growth of the Trial Oversight analytics product line, turning it into a $30 million venture. He also elevated the organization’s ESG ratings in his role as the Chief Diversity, Inclusion, and Sustainability Officer.
Recognized as a PharmaVoice 100 Most Inspiring Industry Leader, a top DE&I Leader by Mogul, and honored with the Healthcare Businesswomen’s Association (HBA) Honorable Mentor Award, Otis's influence extends far beyond his immediate professional circle. In his current role as Co-founder and Principal Consultant of Trial Equity, Otis works to equip clinical research professionals with the knowledge and skills to enroll more representative patient populations into clinical trials to ensure that medicines are safe and effective for all people.
Jeff Zucker, MS (he/him)
Jeff Zucker has over 25 years’ experience in many aspects of the clinical research industry. Starting as a trained psychotherapist, he worked with various populations in both in-patient and out-patient settings. In 1996, he entered the clinical research world by directing a multi-location site in New Jersey focusing on CNS. Joining Eli Lilly as a Regional Research Manager allowed him to drive research on Strattera, Cymbalta, Zyprexa, and other CNS compounds. Within this role, he also established strong relationships with CNS sites and investigators. He served as a consultant to both Pharma and research sites to help develop and optimize operations. His experience also includes running a Phase I unit in New Jersey that worked with various therapeutic areas. He worked with an esteemed Global Trial Optimization team at Merck to focus on trial feasibility and patient recruitment. Joining the CRO world (Kendle, INC, ICON, and Worldwide Clinical Trials), he grew his global experience in all aspects of clinical operations and therapeutic areas.
Strong areas of focus for Jeff are clinical trial operations, site relationships, patient recruitment, feasibility, rater training, and global leadership.